Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

Plerixafor-AFT solution for injection 24 mg/1.2 mL

Approval Number

SIN17147P

Drug Name

Plerixafor-AFT solution for injection 24 mg/1.2 mL

Product Name

Plerixafor-AFT solution for injection 24 mg/1.2 mL

Approval Date

December 12, 2024

Registrant

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

Registrant

APEX PHARMA MARKETING PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

SUBCUTANEOUS

Medical Information

ATC Code

L03AX16

Manufacturer Information

Pharmaceutical Manufacturer

APEX PHARMA MARKETING PTE. LTD.

Manufacturers

Sichuan Huiyu Pharmaceutical Co., Ltd.

Active Ingredients

Ingredient Name

PLERIXAFOR

Strength

24 mg/1.2 mL

Drug MonographPlerixafor

Documents

Package Inserts

PLERIXAFOR-AFT SOLUTION FOR INJECTION PI.pdf

Approved: December 12, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

Plerixafor-AFT solution for injection 24 mg/1.2 mL - HSA Approval | MedPath